{"meta":{"query_hash":"83d4008d5c07","filters":{"venue":"Section 5: Patient safety and quality assurance"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/83d4008d5c07","api":"https://metacan.xera.ac/api/v1/cohort?venue=Section+5%3A+Patient+safety+and+quality+assurance"},"results":[{"id":"W2945764188","doi":"10.1136/ejhpharm-2019-eahpconf.444","title":"5PSQ-011 Venous thromboembolic events and total hip or knee arthroplasty: incidence and associated factors","year":2019,"lang":"en","type":"article","venue":"Section 5: Patient safety and quality assurance","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Rivaroxaban; Dabigatran; Venous thromboembolism; Arthroplasty; Total knee arthroplasty; Medical prescription; Internal medicine; Surgery; Warfarin; Thrombosis; Atrial fibrillation","score_opus":0.021561777971995606,"score_gpt":0.2733416329539053,"score_spread":0.2517798549819097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945764188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98805666,0.0025988598,0.00022466398,0.00056909473,0.000051915096,0.000030105351,0.0053271493,0.000010665984,0.0031308318],"genre_scores_gemma":[0.9967244,0.000519925,0.00012179843,0.00009629419,0.00004350995,0.00001466017,0.0020698654,0.0000019349588,0.00040766702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966073,0.00007422076,0.00004719923,0.00005139333,0.000089129324,0.00007727607],"domain_scores_gemma":[0.9986015,0.00015937816,0.00080808724,0.00002153769,0.00016764607,0.00024193927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042246497,0.00022506328,0.00016734816,0.00094582816,0.0002466518,0.0004463626,0.0002339874,0.00037521854,0.0066582477],"category_scores_gemma":[0.0015286796,0.000090813824,0.00044061465,0.0021054468,0.00022400571,0.00029044095,0.00032364193,0.0003980417,0.0005829703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037420927,0.000016343285,0.9982553,0.000021894777,0.000021726564,0.00007230526,0.000015986938,0.000028771468,0.000042399428,0.000028848013,0.00034788373,0.0011111648],"study_design_scores_gemma":[0.000005691396,0.00004654053,0.99852705,0.000022084465,0.000018037816,0.00046751677,0.00009721697,0.00012623765,0.000021749023,0.000045781642,0.0006196563,0.000002317439],"about_ca_topic_score_codex":0.007337354,"about_ca_topic_score_gemma":0.004245591,"teacher_disagreement_score":0.007337354,"about_ca_system_score_codex":0.00036110796,"about_ca_system_score_gemma":0.0005094939,"threshold_uncertainty_score":0.022274077},"labels":[],"label_agreement":null},{"id":"W4293229876","doi":"10.1136/ejhpharm-2022-eahp.275","title":"5PSQ-041 Safety and efficacy of high doses of irinotecan in patients with metastatic colorectal cancer treated with FOLFIRI scheme based on UGT1A1 genotype: a systematic review","year":2022,"lang":"en","type":"review","venue":"Section 5: Patient safety and quality assurance","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Fundación Vital Fundazioa","keywords":"Irinotecan; Jadad scale; Medicine; FOLFIRI; Internal medicine; Colorectal cancer; Observational study; Oncology; Randomized controlled trial; Meta-analysis; Pharmacology; Cancer; Cochrane Library","score_opus":0.023063522737373294,"score_gpt":0.2923180049184177,"score_spread":0.2692544821810444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293229876","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033682366,0.99363756,0.00012902684,0.00029867413,0.000110654335,0.0002998137,0.0016968325,0.00001343168,0.0004457631],"genre_scores_gemma":[0.042554434,0.9538367,0.0004816405,0.0010476254,0.00011704427,0.00061864837,0.0010894147,0.000008898821,0.0002455452],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99754214,0.0006825197,0.0010015737,0.00027154302,0.00039829384,0.0001039583],"domain_scores_gemma":[0.9891422,0.007088167,0.0024502615,0.00014742206,0.0010294718,0.0001424135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029351208,0.0010499666,0.0065693413,0.005532811,0.0003780669,0.0015664666,0.0011798644,0.0013484168,0.0056200363],"category_scores_gemma":[0.015328563,0.00061449857,0.008288337,0.0060043614,0.00051960564,0.0012382364,0.00094341196,0.00075598276,0.00029099028],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004221413,0.000014471811,0.0016526697,0.9561186,0.018411655,0.000070713875,0.0001029721,0.00010875919,0.00023637766,0.00013078714,0.0013970871,0.021333748],"study_design_scores_gemma":[0.0007443122,0.0004700595,0.014461721,0.7253926,0.23873799,0.0005606425,0.00025065403,0.00015673632,0.00025370892,0.00038844591,0.01852764,0.00005548765],"about_ca_topic_score_codex":0.0075793928,"about_ca_topic_score_gemma":0.019885276,"teacher_disagreement_score":0.0075793928,"about_ca_system_score_codex":0.0022200688,"about_ca_system_score_gemma":0.0057288096,"threshold_uncertainty_score":0.018800855},"labels":[],"label_agreement":null},{"id":"W4360614809","doi":"10.1136/ejhpharm-2023-eahp.324","title":"5PSQ-134 Unit dose in a cyberattack scenario","year":2023,"lang":"en","type":"article","venue":"Section 5: Patient safety and quality assurance","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical prescription; Pharmacy; Computer science; Workstation; Medical emergency; Service (business); Medicine; Operating system; Nursing","score_opus":0.08673984244305188,"score_gpt":0.3551708130173303,"score_spread":0.2684309705742784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360614809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93217486,0.001809438,0.007188914,0.019738082,0.00047892993,0.00028350946,0.0010442565,0.00051404594,0.036768023],"genre_scores_gemma":[0.99052143,0.0005705538,0.0022864307,0.0019695102,0.00017955994,0.000046870013,0.00027415235,0.000075425625,0.004076073],"study_design_codex":"case_report","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99855846,0.00047506028,0.00014138203,0.00017772219,0.0002844419,0.00036285556],"domain_scores_gemma":[0.9980324,0.00063530233,0.00041735946,0.00012719334,0.00015577191,0.0006320511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008291344,0.00034965156,0.000410951,0.0005961467,0.001708169,0.0017025329,0.0008507294,0.0023198107,0.010368451],"category_scores_gemma":[0.0031777162,0.00033765525,0.0005484377,0.00072211726,0.0012136266,0.0013517367,0.0020680213,0.0017711958,0.0018055394],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028251952,0.0021902884,0.20037079,0.0008023222,0.00010880547,0.63575816,0.006975727,0.014046921,0.005841788,0.017222838,0.04433759,0.069519535],"study_design_scores_gemma":[0.0003918725,0.00441922,0.094301306,0.0008725806,0.00017784897,0.6596436,0.018097267,0.039874148,0.01427087,0.014981582,0.15263753,0.00033212084],"about_ca_topic_score_codex":0.005159858,"about_ca_topic_score_gemma":0.0052039637,"teacher_disagreement_score":0.010368451,"about_ca_system_score_codex":0.0026708485,"about_ca_system_score_gemma":0.0012384079,"threshold_uncertainty_score":0.03468585},"labels":[],"label_agreement":null}]}